Americaine Aerosol, Spray
NDC Package 63736-378-02
Package Information
Americaine (benzocaine) aerosols is shake can well, hold 6" to 12" from affected area; spray liberally.adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times dailychildren under 2 years of age: consult a physician. This formulation utilizes a aerosol, spray delivery system. Marketed by Insight Pharmaceuticals Llc, this product is identified by NDC 63736-378 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 211315 - Americaine 20 % Topical Spray
- RxCUI: 211315 - benzocaine 200 MG/ML Topical Spray [Americaine]
- RxCUI: 211315 - Americaine 200 MG/ML Topical Spray
- RxCUI: 360349 - benzocaine 20 % Topical Spray
- RxCUI: 360349 - benzocaine 200 MG/ML Topical Spray
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63736 - Insight Pharmaceuticals Llc
- 63736-378 - Americaine
- 63736-378-02 - 57 g in 1 CAN
- 63736-378 - Americaine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63736-378-02 identifies a specific commercial package of 57 g in 1 can of Americaine, a human over the counter drug labeled by Insight Pharmaceuticals Llc. This aerosol, spray is formulated for topical use and contains benzocaine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Insight Pharmaceuticals Llc on July 14, 2009. The current certification is valid through December 31, 2026.
How is this Insight Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63736037802. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.